WHITEHAWK THERAPEUTICS, INC. Allowance for Doubtful Accounts, Premiums and Other Receivables
WHITEHAWK THERAPEUTICS, INC. (WHWK) had Allowance for Doubtful Accounts, Premiums and Other Receivables of $100.00 thousand as of 2024-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Balance Sheet › Assets
us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables · last filed 2026-03-12
- 2024-12-31: Allowance for Doubtful Accounts, Premiums and Other Receivables $100.00K.
- 2024-09-30: Allowance for Doubtful Accounts, Premiums and Other Receivables $32.00K.
- 2024-06-30: Allowance for Doubtful Accounts, Premiums and Other Receivables $100.00K.
- 2024-03-31: Allowance for Doubtful Accounts, Premiums and Other Receivables $100.00K.
| Period end | Allowance for Doubtful Accounts, Premiums and Other Receivables |
|---|---|
| 2024-12-31 | $100.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $32.00K 10-Q · filed 2024-11-06 |
| 2024-06-30 | $100.00K 10-Q · filed 2024-08-07 |
| 2024-03-31 | $100.00K 10-Q · filed 2024-05-08 |
| 2023-12-31 | $200.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | $1.50M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $1.20M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $800.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $100.00K 10-K · filed 2024-03-13 |
| 2022-09-30 | $100.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $100.00K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-12 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-29 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-10 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |